GeneDx Stock Based Compensation from 2010 to 2024

WGS Stock

78.39 1.04 1.31%

GeneDx Holdings Stock Based Compensation yearly trend continues to be comparatively stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2024. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2010-12-31

Previous Quarter

-326 K

Current Value

-309.7 K

Quarterly Volatility

60.9 M

Credit Downgrade

Yuan Drop

Covid

Check GeneDx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeneDx Holdings' main balance sheet or income statement drivers, such as Net Interest Income of 1.2 M, Interest Income of 3.1 M or Depreciation And Amortization of 30.9 M, as well as many indicators such as Price To Sales Ratio of 0.31, Dividend Yield of 0.0 or PTB Ratio of 0.52. GeneDx financial statements analysis is a perfect complement when working with GeneDx Holdings Valuation or Volatility modules.

Check out the analysis of GeneDx Holdings Correlation against competitors.

Latest GeneDx Holdings' Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of GeneDx Holdings Corp over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. GeneDx Holdings' Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeneDx Holdings' overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

GeneDx Stock Based Compensation Regression Statistics

	Arithmetic Mean	29,054,087
	Geometric Mean	6,748,216
	Coefficient Of Variation	209.77
	Mean Deviation	39,261,965
	Median	5,482,000
	Standard Deviation	60,945,875
	Sample Variance	3714.4T
	Range	219.7M
	R-Value	0.34
	Mean Square Error	3530.8T
	R-Squared	0.12
	Significance	0.21
	Slope	4,668,136
	Total Sum of Squares	52001.6T

GeneDx Stock Based Compensation History

	2024	-309.7 K
	2023	-326 K
	2022	42 M
	2021	219.4 M
	2020	120.2 M

Other Fundumenentals of GeneDx Holdings Corp

Stock Based Compensation To Revenue

GeneDx Holdings Stock Based Compensation component correlations

	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Deferred Long Term Liab	Total Current Assets	Property Plant Equipment	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Long Term Debt	Total Liab	Net Invested Capital	Short Long Term Debt	Net Working Capital	Short Term Debt	Common Stock	Long Term Debt Total	Capital Surpluse	Intangible Assets
Net Tangible Assets		-0.81	0.34	0.57	0.6	0.71	0.69	0.95	0.95	-0.92	-0.26	0.38	-0.95	0.95	0.33	0.56	0.16	-0.38	-0.56	-0.56	-0.53
Retained Earnings	-0.81		-0.2	-0.88	-0.81	-0.39	-0.94	-0.88	-0.87	0.97	-0.17	-0.6	0.89	-0.88	-0.07	-0.18	-0.37	0.51	0.74	0.74	0.68
Accounts Payable	0.34	-0.2		0.46	0.51	0.6	0.34	0.48	0.51	-0.33	-0.68	-0.64	-0.46	0.49	0.97	0.48	0.39	0.63	0.39	0.39	0.37
Net Receivables	0.57	-0.88	0.46		0.84	0.28	0.9	0.74	0.74	-0.83	0.15	0.26	-0.75	0.73	0.3	0.02	0.65	-0.12	-0.46	-0.46	-0.44
Deferred Long Term Liab	0.6	-0.81	0.51	0.84		0.54	0.94	0.8	0.82	-0.79	-0.19	0.26	-0.81	0.82	0.33	0.4	0.18	-0.24	-0.36	-0.36	-0.29
Total Current Assets	0.71	-0.39	0.6	0.28	0.54		0.38	0.76	0.75	-0.56	-0.8	-0.03	-0.74	0.74	0.58	0.95	-0.18	-0.1	-0.19	-0.19	-0.21
Property Plant Equipment	0.69	-0.94	0.34	0.9	0.94	0.38		0.83	0.84	-0.9	0.07	0.45	-0.85	0.85	0.18	0.21	0.3	-0.38	-0.53	-0.53	-0.45
Total Assets	0.95	-0.88	0.48	0.74	0.8	0.76	0.83		1.0	-0.96	-0.3	0.34	-1.0	1.0	0.41	0.59	0.21	-0.33	-0.54	-0.54	-0.51
Total Stockholder Equity	0.95	-0.87	0.51	0.74	0.82	0.75	0.84	1.0		-0.96	-0.32	0.3	-1.0	1.0	0.44	0.59	0.21	-0.3	-0.49	-0.49	-0.45
Current Deferred Revenue	-0.92	0.97	-0.33	-0.83	-0.79	-0.56	-0.9	-0.96	-0.96		0.03	-0.48	0.97	-0.96	-0.25	-0.36	-0.34	0.42	0.66	0.66	0.62
Net Debt	-0.26	-0.17	-0.68	0.15	-0.19	-0.8	0.07	-0.3	-0.32	0.03		0.52	0.27	-0.3	-0.72	-0.88	0.34	-0.35	-0.41	-0.41	-0.38
Long Term Debt	0.38	-0.6	-0.64	0.26	0.26	-0.03	0.45	0.34	0.3	-0.48	0.52		-0.36	0.33	-0.72	-0.06	-0.2	-0.97	-0.92	-0.92	-0.86
Total Liab	-0.95	0.89	-0.46	-0.75	-0.81	-0.74	-0.85	-1.0	-1.0	0.97	0.27	-0.36		-1.0	-0.39	-0.56	-0.22	0.35	0.56	0.56	0.52
Net Invested Capital	0.95	-0.88	0.49	0.73	0.82	0.74	0.85	1.0	1.0	-0.96	-0.3	0.33	-1.0		0.41	0.58	0.2	-0.32	-0.51	-0.51	-0.46
Short Long Term Debt	0.33	-0.07	0.97	0.3	0.33	0.58	0.18	0.41	0.44	-0.25	-0.72	-0.72	-0.39	0.41		0.48	0.37	0.7	0.48	0.48	0.45
Net Working Capital	0.56	-0.18	0.48	0.02	0.4	0.95	0.21	0.59	0.59	-0.36	-0.88	-0.06	-0.56	0.58	0.48		-0.46	-0.12	-0.05	-0.05	-0.05
Short Term Debt	0.16	-0.37	0.39	0.65	0.18	-0.18	0.3	0.21	0.21	-0.34	0.34	-0.2	-0.22	0.2	0.37	-0.46		0.41	-0.05	-0.05	-0.09
Common Stock	-0.38	0.51	0.63	-0.12	-0.24	-0.1	-0.38	-0.33	-0.3	0.42	-0.35	-0.97	0.35	-0.32	0.7	-0.12	0.41		0.86	0.86	0.8
Long Term Debt Total	-0.56	0.74	0.39	-0.46	-0.36	-0.19	-0.53	-0.54	-0.49	0.66	-0.41	-0.92	0.56	-0.51	0.48	-0.05	-0.05	0.86		1.0	0.99
Capital Surpluse	-0.56	0.74	0.39	-0.46	-0.36	-0.19	-0.53	-0.54	-0.49	0.66	-0.41	-0.92	0.56	-0.51	0.48	-0.05	-0.05	0.86	1.0		0.99
Intangible Assets	-0.53	0.68	0.37	-0.44	-0.29	-0.21	-0.45	-0.51	-0.45	0.62	-0.38	-0.86	0.52	-0.46	0.45	-0.05	-0.09	0.8	0.99	0.99

Click cells to compare fundamentals

About GeneDx Holdings Financial Statements

GeneDx Holdings shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although GeneDx Holdings investors may analyze each financial statement separately, they are all interrelated. The changes in GeneDx Holdings' assets and liabilities, for example, are also reflected in the revenues and expenses on on GeneDx Holdings' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Stock Based Compensation	-326 K	-309.7 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

GeneDx Stock Based Compensation from 2010 to 2024

Latest GeneDx Holdings' Stock Based Compensation Growth Pattern

GeneDx Stock Based Compensation Regression Statistics

GeneDx Stock Based Compensation History

Other Fundumenentals of GeneDx Holdings Corp

GeneDx Holdings Stock Based Compensation component correlations

About GeneDx Holdings Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for GeneDx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY